Jazz Pharmaceuticals plc Public Float
Jazz Pharmaceuticals plc (JAZZ) had Public Float of $6.25 billion as of 2025-06-30, per its 10-K/A filed 2026-04-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-24
- 2025-06-30: Entity Public Float $6.25B.
- 2024-06-28: Entity Public Float $6.41B.
- 2023-06-30: Entity Public Float $7.66B.
- 2022-06-30: Entity Public Float $9.53B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.25B 10-K/A · filed 2026-04-24 |
| 2024-06-28 | $6.41B 10-K/A · filed 2025-04-25 |
| 2023-06-30 | $7.66B 10-K/A · filed 2024-04-26 |
| 2022-06-30 | $9.53B 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $10.59B 10-K/A · filed 2022-05-02 |
| 2020-06-30 | $5.96B 10-K/A · filed 2021-04-23 |
| 2019-06-28 | $7.87B 10-K/A · filed 2020-04-24 |
| 2018-06-30 | $7.52B 10-K · filed 2019-02-26 |
| 2017-06-30 | $6.71B 10-K · filed 2018-02-27 |
| 2016-06-30 | $5.55B 10-K · filed 2017-02-28 |
| 2015-06-30 | $7.45B 10-K · filed 2016-02-23 |
| 2014-06-30 | $8.42B 10-K · filed 2015-02-24 |
| 2013-06-28 | $3.53B 10-K · filed 2014-02-25 |
| 2012-06-29 | $1.95B 10-K · filed 2013-02-26 |
| 2011-06-30 | $769.14M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |